EDN1 and cancer: IL-6 released from MSCs stimulates the release of endothelin-1 (ET-1) in cancer cells, which in turn triggers the activation of Akt and ERK in endothelial cells, improving their ability to attract other cells to the tumor and promoting angiogenesis (227).